Cited by 97Immunodeficiency and Autoimmune DisordersGenomics and Rare DiseasesBlood disorders and treatments

Incomplete penetrance in primary immunodeficiency: a skeleton in the closet

Open access
Gruber, Conor, Bogunovic, Dusan·2020·Human Genetics

Abstract

Primary immunodeficiencies (PIDs) comprise a diverse group of over 400 genetic disorders that result in clinically apparent immune dysfunction. Although PIDs are classically considered as Mendelian disorders with complete penetrance, we now understand that absent or partial clinical disease is often noted in individuals harboring disease-causing genotypes. Despite the frequency of incomplete penetrance in PID, no conceptual framework exists to categorize and explain these occurrences. Here, by reviewing decades of reports on incomplete penetrance in PID we identify four recurrent themes of incomplete penetrance, namely genotype quality, (epi)genetic modification, environmental influence, and mosaicism. For each of these principles, we review what is known, underscore what remains unknown, and propose future experimental approaches to fill the gaps in our understanding. Although the content herein relates specifically to inborn errors of immunity, the concepts are generalizable across genetic diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00439-020-02131-9

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The study could not correctly assess the influence of environmental factors and modifier genes on penetrance of APOE mutations.

    “Meanwhile, it also prevents the correct and comprehensive assessment of the influence of environmental factors and modifier genes on the penetrance of APOE mutations9,18, 19, 20, 21”

    From The First Case of Lipoprotein Glomerulopathy in a Patient With Male Infertility (2026) · cites this paper as [19]

    The Conclusions (page unavailable) identify environmental influences and genetic modifiers as factors that affect penetrance in primary immunodeficiency. The paper does not assess APOE mutations or say that a study could not adequately assess those factors for APOE; a search for APOE found no matching passage. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 153

  1. Abel L (2010) ‘ Age-dependent mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood’, Journal of Pediatrics, 157(4). doi: 10.1016/j.jpeds.2010.04.020. 20553844 · DOI
  2. Adegbola AA (2015) ‘ Monoallelic expression of the human FOXP2 speech gene’, Proceedings of the National Academy of Sciences, 112(22), pp. 6848– 6854. doi: 10.1073/pnas.1411270111. PMC4460484 25422445 · DOI
  3. Al-Mousa H (2016) ‘ Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases’, Journal of Allergy and Clinical Immunology. Elsevier Ltd, 137(6), pp. 1780– 1787. doi: 10.1016/j.jaci.2015.12.1310. 26915675 · DOI
  4. Aldrich RA, Steinberg AG and Campbell DC (1954) ‘ Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea.’, Pediatrics, 13(2), pp. 133– 9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/13133561. 13133561
  5. Ameratunga R (2017) ‘ Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus’, Clinical & Translational Immunology. Nature Publishing Group, 6(10), p. e159. doi: 10.1038/cti.2017.41. PMC5671988 29114388 · DOI
  6. Andersen LL (2015) ‘ Functional IRF3 deficiency in a patient with herpes simplex encephalitis’, Journal of Experimental Medicine, 212(9), pp. 1371– 1379. doi: 10.1084/jem.20142274. 26216125 PMC4548062 · DOI
  7. Ariga T, Kondoh T, (2001) ‘ Spontaneous In Vivo Reversion of an Inherited Mutation in the Wiskott-Aldrich Syndrome’, The Journal of Immunology, 166(8), pp. 5245– 5249. doi: 10.4049/jimmunol.166.8.5245. 11290809 · DOI
  8. Ariga T, Oda N, (2001) ‘ T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation’, Blood, 97(9), pp. 2896– 2899. doi: 10.1182/blood.V97.9.2896. 11313286 · DOI
  9. Arredondo-Vega FX (1990) ‘ Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combined immunodeficiency’, Journal of Clinical Investigation, 86(2), pp. 444– 452. doi: 10.1172/JCI114730. 1974554 PMC296746 · DOI
  10. Ban SA (2014) ‘ Combined Immunodeficiency Evolving into Predominant CD4+ Lymphopenia Caused by Somatic Chimerism in JAK3’, Journal of Clinical Immunology, 34(8), pp. 941– 953. doi: 10.1007/s10875-014-0088-2. 25205547 PMC4220108 · DOI
  11. Baradaran-Heravi A (2012) ‘ Penetrance of biallelic SMARCAL1 mutations is associated with environmental and genetic disturbances of gene expression’, Human Molecular Genetics, 21(11), pp. 2572– 2587. doi: 10.1093/hmg/dds083. 22378147 PMC3349428 · DOI
  12. de Beaucoudrey L (2011) ‘ Revisiting Human IL-12Rbeta1 Deficiency: A Survey of 141 Patients From 30 Countries’, Medicine, 89(5), pp. 381– 402. doi: 10.1097/MD.0b013e3181fdd832.Revisiting. PMC3129625 21057261 · DOI
  13. Del Bel KL (2017) ‘ JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome’, Journal of Allergy and Clinical Immunology, 1(6). doi: 10.1016/j.jaci.2016.12.957. 28111307 · DOI
  14. Bleesing JJH (2001) ‘ Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome’, Blood, 98(8), pp. 2466– 2473. doi: 10.1182/blood.V98.8.2466. 11588044 · DOI
  15. Bogaert DJA (2016) ‘ Genes associated with common variable immunodeficiency: One diagnosis to rule them all?’, Journal of Medical Genetics, 53(9), pp. 575– 590. doi: 10.1136/jmedgenet-2015-103690. 27250108 · DOI · Paper page
  16. Boisson-Dupuis S (2018) ‘ Tuberculosis and impaired IL-23–dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant’, Science Immunology, 3(30), p. eaau8714. doi: 10.1126/sciimmunol.aau8714. 30578352 PMC6341984 · DOI
  17. Boisson B (2013) ‘ A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR- B cells’, Journal of Clinical Investigation, 123(11), pp. 4781– 4785. doi: 10.1172/JCI71927. 24216514 PMC3809807 · DOI
  18. Bökenkamp A (2005) ‘ R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia’, Pediatric Nephrology, 20(12), pp. 1724– 1728. doi: 10.1007/s00467-005-2047-x. 16237566 · DOI
  19. Bolze A (2018) ‘ Incomplete penetrance for isolated congenital asplenia in humans with mutations in translated and untranslated RPSA exons’, Proceedings of the National Academy of Sciences of the United States of America, 115(34), pp. E8007– E8016. doi: 10.1073/pnas.1805437115. 30072435 PMC6112730 · DOI
  20. Borel C (2015) ‘ Biased allelic expression in human primary fibroblast single cells’, American Journal of Human Genetics. The American Society of Human Genetics, 96(1), pp. 70– 80. doi: 10.1016/j.ajhg.2014.12.001. PMC4289680 25557783 · DOI · Paper page
  21. Boztug K (2007) ‘ Large granular lymphocyte proliferation and revertant mosaicism: two rare events in a Wiskott-Aldrich syndrome patient.’, Haematologica, 92(3), pp. 43– 45. doi: 10.3324/haematol.11222. 17405757 · DOI
  22. Boztug K (2008) ‘ Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome’, Clinical Genetics, 74(1), pp. 68– 74. doi: 10.1111/j.1399-0004.2008.01019.x. 18479478 · DOI
  23. Bradley H (2014) ‘ Seroprevalence of herpes simplex virus types 1 and 2-United States, 1999–2010’, Journal of Infectious Diseases, 209(3), pp. 325– 333. doi: 10.1093/infdis/jit458. 24136792 · DOI
  24. Bradshaw G (2018) ‘ Exome sequencing diagnoses X-linked moesin-associated immunodeficiency in a primary immunodeficiency case’, Frontiers in Immunology, 9(3). doi: 10.3389/fimmu.2018.00420. PMC5845094 29556235 · DOI
  25. Bruton O (1952) ‘ Agammaglobulinemia’, Pediatrics, 9(6). 14929630
  26. van der Burg M (2000) ‘ Autoimmune Lymphoproliferative Syndrome (ALPS) in a Child from Consanguineous Parents: A Dominant or Recessive Disease?’, Pediatric Research, 47(3), pp. 336– 343. doi: 10.1203/00006450-200003000-00009. 10709732 · DOI
  27. Bustamante J (2014) ‘ Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity’, Semin Immunol, 26(6), pp. 454– 470. doi: 10.1016/j.smim.2014.09.008. 25453225 PMC4357480 · DOI
  28. Cady J (2015) ‘ Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes’, Annals of Neurology, 77(1), pp. 100– 113. doi: 10.1002/ana.24306. 25382069 PMC4293318 · DOI
  29. Candotti F (2017) ‘ Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrom’, Journal of Clinical Immunology, 38(1). 29086100
  30. Casrouge A (2006) ‘ Herpes simplex virus encephalitis in human UNC-93B deficiency’, Science, 314(5797), pp. 308– 312. doi: 10.1126/science.1128346. 16973841 · DOI
  31. Cerutti E (2007) ‘ Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome’, BMC Immunology, 8, pp. 1– 9. doi: 10.1186/1471-2172-8-28. 17999750 PMC2211507 · DOI
  32. Chapgier A (2006) ‘ Human Complete Stat-1 Deficiency Is Associated with Defective Type I and II IFN Responses In Vitro but Immunity to Some Low Virulence Viruses In Vivo’, The Journal of Immunology, 176(8), pp. 5078– 5083. doi: 10.4049/jimmunol.176.8.5078. 16585605 · DOI
  33. Chapgier A (2009) ‘ A partial form of recessive STAT1 deficiency in humans’, Journal of Clinical Investigation, 119(6), pp. 1502– 1514. doi: 10.1172/JCI37083. 19436109 PMC2689115 · DOI
  34. Chinen J and Shearer WT (2010) ‘ Secondary immunodeficiencies, including HIV infection’, Journal of Allergy and Clinical Immunology. Elsevier Ltd, 125(2 SUPPL. 2), pp. S195– S203. doi: 10.1016/j.jaci.2009.08.040. 20042227 PMC6151868 · DOI
  35. Chinn IK (2017) ‘ Novel combined immune deficiency and radiation sensitivity blended phenotype in an adult with biallelic variations in ZAP70 and RNF168’, Frontiers in Immunology, 8(MAY). doi: 10.3389/fimmu.2017.00576. PMC5445153 28603521 · DOI
  36. Christodoulou K (2013) ‘ Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes’, Gut, 62(7), pp. 977– 984. doi: 10.1136/gutjnl-2011-301833. 22543157 PMC3686259 · DOI
  37. Clementi R (2004) ‘ Inherited Perforin and Fas Mutations in a Patient with Autoimmune Lymphoproliferative Syndrome and Lymphoma’, New England Journal of Medicine, 351(14), pp. 1419– 1424. doi: 10.1056/NEJMoa041432. 15459303 · DOI
  38. Le Deist F (1996) ‘ Clinical, immunological, and pathological consequences of Fas-deficient conditions’, The Lancet, 348(9029), pp. 719– 723. doi: 10.1016/S0140-6736(96)02293-3. 8806292 · DOI
  39. Dekel B (2008) ‘ Schimke immuno-osseous dysplasia: Expression of SMARCAL1 in blood and kidney provides novel insight into disease phenotype’, Pediatric Research, 63(4), pp. 398– 403. doi: 10.1203/PDR.0b013e31816721cc. 18356746 · DOI
  40. Deng Q (2014) ‘Single-Cell RNA-Seq Reveals Dynamic, Random Monoallelic Gene Expression in Mammalian Cells’, 343(1). doi: 10.1126/science.1245316. 24408435 · DOI · Paper page
  41. Dorman SE (2004) ‘ Clinical features of dominant and recessive interferon γ receptor 1 deficiencies’, Lancet, 364(9451), pp. 2113– 2121. doi: 10.1016/S0140-6736(04)17552-1. 15589309 · DOI
  42. Dowdell KC (2010) ‘ Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome’, Blood, 115(25), pp. 5164– 5169. doi: 10.1182/blood-2010-01-263145. 20360470 PMC2892951 · DOI
  43. Duncan CJA (2015) ‘ Human IFNAR2 deficiency: lessons for antiviral immunity Europe PMC Funders Group’, Sci Transl Med, 7(307), pp. 307– 154. doi: 10.1126/scitranslmed.aac4227. PMC4926955 26424569 · DOI
  44. Dupuis S (2001) ‘ Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation’, Science, 293(5528), pp. 300– 303. doi: 10.1126/science.1061154. 11452125 · DOI
  45. Dupuis S (2003) ‘ Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency’, Nature Genetics, 33(3), pp. 388– 391. doi: 10.1038/ng1097. 12590259 · DOI
  46. El-Brolosy M (2019) ‘ Genetic compensation is triggered by mutant mRNA degradation’, Nature, p. 328153. doi: 10.1101/328153. PMC6707827 30944477 · DOI
  47. Elizonod LI (2009) ‘ Schimke immuno-osseous dysplasia: SMARCAL1 loss-of-function and phenotypic correlation’, Journal of Medical Genetics, 46(1), pp. 49– 59. doi: 10.1136/jmg.2008.060095. 18805831 · DOI
  48. Feldmann J (2002) ‘ Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis’, British Journal of Haematology, 117(4), pp. 965– 972. doi: 10.1046/j.1365-2141.2002.03534.x. 12060139 · DOI
  49. Felgentreff K (2016) ‘ Ligase-4 Deficiency Causes Distinctive Immune Abnormalities in Asymptomatic Individuals’, Journal of Clinical Immunology. Journal of Clinical Immunology, 36(4), pp. 341– 353. doi: 10.1007/s10875-016-0266-5. 27063650 PMC4842108 · DOI
  50. Fiedorová K (2019) ‘ Bacterial but not fungal gut microbiota alterations are associated with common variable immunodeficiency (CVID) phenotype’, Frontiers in Immunology, 10(8). doi: 10.3389/fimmu.2019.01914. PMC6700332 31456808 · DOI
  51. Fieschi C (2003) ‘ Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor β1 deficiency: Medical and immunological implications’, Journal of Experimental Medicine, 197(4), pp. 527– 535. doi: 10.1084/jem.20021769. 12591909 PMC2193866 · DOI
  52. Gámez-Díaz L (2016) ‘ The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency’, Journal of Allergy and Clinical Immunology, 137(1), pp. 223– 230. doi: 10.1016/j.jaci.2015.09.025. 26768763 · DOI
  53. Gendrel AV (2014) ‘ Developmental dynamics and disease potential of random monoallelic gene expression’, Developmental Cell. Elsevier Inc., 28(4), pp. 366– 380. doi: 10.1016/j.devcel.2014.01.016. 24576422 · DOI
  54. Gilbert JA (2018) ‘ Current understanding of the human microbiome’, Nature Medicine, 24(4), pp. 392– 400. doi: 10.1038/nm.4517. PMC7043356 29634682 · DOI · Paper page
  55. Gimelbrant A (2007) ‘ Widespread monoallelic expression on human autosomes’, Science, 318(5853), pp. 1136– 1140. doi: 10.1126/science.1148910. 18006746 · DOI · Paper page
  56. Girard SL (2015) ‘ Mutation burden of rare variants in schizophrenia candidate genes’, PLoS ONE, 10(6), pp. 1– 11. doi: 10.1371/journal.pone.0128988. PMC4454531 26039597 · DOI
  57. Green MR (2011) ‘ A novel immunodeficiency disorder characterized by genetic amplification of interleukin 25’, Genes and Immunity. Nature Publishing Group, 12(8), pp. 663– 666. doi: 10.1038/gene.2011.50. 21776014 · DOI
  58. Gruber C (2019) ‘ Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Transcriptional and Biochemical Function’, bioRxiv, p. 807669. doi: 10.1101/807669. PMC7398039 32750333 · DOI
  59. Guo MH (2018) ‘ Burden Testing of Rare Variants Identified through Exome Sequencing via Publicly Available Control Data’, American Journal of Human Genetics. ElsevierCompany, 103(4), pp. 522– 534. doi: 10.1016/j.ajhg.2018.08.016. PMC6174288 30269813 · DOI
  60. Guo Y (2011) ‘ Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity’, Journal of Experimental Medicine, 208(10), pp. 2083– 2098. doi: 10.1084/jem.20101568. 21911422 PMC3182056 · DOI
  61. Hambleton S (2013) ‘ STAT2 deficiency and susceptibility to viral illness in humans’, Proceedings of the National Academy of Sciences, 110(8), pp. 3053– 3058. doi: 10.1073/pnas.1220098110. PMC3581986 23391734 · DOI
  62. Hauck F (2013) ‘ Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation’, Clinical Immunology. Elsevier Inc., 147(1), pp. 61– 68. doi: 10.1016/j.clim.2013.02.019. 23524443 · DOI
  63. Herman M (2012) ‘ Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood’, Journal of Experimental Medicine, 209(9), pp. 1567– 1582. doi: 10.1084/jem.20111316. 22851595 PMC3428952 · DOI
  64. Hirschhorn R (1994) ‘ Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery’, American Journal of Human Genetics, 55(1), pp. 59– 68. 8023852 PMC1918232
  65. Hoffmann F (2005) ‘ Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V3771 substitution and the low-penetrance TNFRSF1A R92Q mutation’, European Journal of Human Genetics, 13(4), pp. 510– 512. doi: 10.1038/sj.ejhg.5201352. 15657603 · DOI
  66. Holzelova E, Vonarbourg C, Stolzenberg MC, (2004) ‘ Autoimmune lymphoproliferative syndrome with somatic Fas mutations’, New England Journal of Medicine, 351(14), pp. 1409– 1418. doi: 10.1056/NEJMoa040036. 15459302 · DOI
  67. Holzelova E, Vonarbourg C, Stolzenberg M-C, (2004) ‘ Autoimmune Lymphoproliferative Syndrome with Somatic Fas Mutations’, New England Journal of Medicine, 351(14), pp. 1409– 1418. doi: 10.1056/NEJMoa040036. 15459302 · DOI
  68. Hoyos-Bachiloglu R (2017) ‘ A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations’, Journal of Clinical Investigation, 127(12), pp. 4415– 4420. doi: 10.1172/JCI93486. 29106381 PMC5707159 · DOI
  69. Hsu AP (2013) ‘ Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism’, Journal of Allergy and Clinical Immunology, 131(6), pp. 1586– 1593. doi: 10.1016/j.jaci.2013.02.038. 23623265 PMC4103905 · DOI
  70. Infante AJ (1998) ‘ The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis’, Journal of Pediatrics, 133(5), pp. 629– 633. doi: 10.1016/S0022-3476(98)70102-7. 9821419 · DOI
  71. Israel L (2017) ‘ Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity’, Cell, 168(5), pp. 789– 800.e10. doi: 10.1016/j.cell.2017.01.039. 28235196 PMC5328639 · DOI
  72. Jackson CE (1999) ‘ Autoimmune lymphoproliferative syndrome with defective Fas: Genotype influences penetrance’, American Journal of Human Genetics, 64(4), pp. 1002– 1014. doi: 10.1086/302333. 10090885 PMC1377824 · DOI
  73. Jägle S (2019) ‘ Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity’, Clinical Immunology. Elsevier, 210(November 2019), p. 108316. doi: 10.1016/j.clim.2019.108316. 31770611 · DOI
  74. Jeffries AR (2012) ‘ Stochastic choice of allelic expression in human neural stem cells’, Stem Cells, 30(9), pp. 1938– 1947. doi: 10.1002/stem.1155. 22714879 · DOI
  75. Jing H (2014) ‘ Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype’, Journal of Allergy and Clinical Immunology. Elsevier Ltd, 133(6), pp. 1667– 1675. doi: 10.1016/j.jaci.2014.03.025. PMC4132167 24797421 · DOI
  76. Jørgensen SF (2016) ‘ Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation’, Mucosal Immunology, 9(6), pp. 1455– 1465. doi: 10.1038/mi.2016.18. 26982597 · DOI
  77. Jouanguy E (1996) ‘ Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection’, New England Journal of Medicine, 335(26), pp. 1956– 1962. doi: 10.1056/NEJM199612263352604. 8960475 · DOI
  78. Jouanguy E (1999) ‘ A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection’, Nature Genetics, 21(4), pp. 370– 378. doi: 10.1038/7701. 10192386 · DOI
  79. Kadowaki T (2018) ‘ Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders’, Journal of Allergy and Clinical Immunology, 141(4), pp. 1485– 1488.e11. doi: 10.1016/j.jaci.2017.10.039. 29241730 · DOI
  80. Kasahara Y (1998) ‘ Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder’, International Immunology, 10(2), pp. 195– 202. doi: 10.1093/intimm/10.2.195. 9533447 · DOI
  81. Keller M (2014) ‘ Burden of copy number variation in common variable immunodeficiency’, Clinical and Experimental Immunology, 177(1), pp. 269– 271. doi: 10.1111/cei.12255. 24329717 PMC4089176 · DOI
  82. Kerner G (2019) ‘ Homozygosity for TYK2 P1104A underlies tuberculosis in about 1% of patients in a cohort of European ancestry’, Proceedings of the National Academy of Sciences of the United States of America, 116(21), pp. 10430– 10434. doi: 10.1073/pnas.1903561116. 31068474 PMC6534977 · DOI
  83. Kong XF (2010) ‘ A novel form of human STAT1 deficiency impairing early but not late responses to interferons’, Blood, 116(26), pp. 5896– 5906. doi: 10.1182/blood-2010-04-280586. PMC3031383 20841510 · DOI
  84. Kong XF (2013) ‘ Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease’, Human Molecular Genetics, 22(4), pp. 769– 781. doi: 10.1093/hmg/dds484. 23161749 PMC3554203 · DOI
  85. de Koning HD (2015) ‘ Myeloid lineage–restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome’, Journal of Allergy and Clinical Immunology, 135(2), pp. 561– 564.e4. doi: 10.1016/j.jaci.2014.07.050. 25239704 · DOI
  86. Kreins AY (2015) ‘ Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome’, The Journal of Experimental Medicine, 212(10), pp. 1641– 1662. doi: 10.1084/jem.20140280. 26304966 PMC4577846 · DOI
  87. Kristensen IA (2011) ‘ Novel STAT1 alleles in a patient with impaired resistance to mycobacteria’, Journal of Clinical Immunology, 31(2), pp. 265– 271. doi: 10.1007/s10875-010-9480-8. 21057861 · DOI
  88. Kuehn HS (2011) ‘ FAS Haploinsufficiency Is a Common Disease Mechanism in the Human Autoimmune Lymphoproliferative Syndrome’, The Journal of Immunology, 186(10), pp. 6035– 6043. doi: 10.4049/jimmunol.1100021. 21490157 PMC3725553 · DOI
  89. Kuehn HS (2014) ‘ Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4’, Science, 345(6204), pp. 1623– 1627. doi: 10.1126/science.1255904. 25213377 PMC4371526 · DOI
  90. Lim HK (2014) ‘ TLR3 deficiency in herpes simplex encephalitis’, Neurology, 83, pp. 1888– 1897. doi: 10.1212/WNL.0000000000000999. 25339207 PMC4248460 · DOI
  91. Lopez-Herrera G (2012) ‘ Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity’, American Journal of Human Genetics, 90(6), pp. 986– 1001. doi: 10.1016/j.ajhg.2012.04.015. 22608502 PMC3370280 · DOI
  92. Lutz W (1946) ‘ A propos de l’Epidermodysplasie verruciforme’, Dermatology, 92(1), pp. 30– 43. doi: 10.1159/000255805. 20982046 · DOI
  93. Ma CA (2017) ‘ Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea.’, Blood, 129(5), pp. 650– 653. doi: 10.1182/blood-2016-09-737817. 27956386 PMC5290989 · DOI
  94. Ma Z (2019) ‘ PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components’, Nature. Springer US, 12. doi: 10.1038/s41586-019-1057-y. 30944473 · DOI
  95. Magerus-Chatinet A (2011) ‘ Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation’, Journal of Clinical Investigation, 121(1), pp. 106– 112. doi: 10.1172/JCI43752. 21183795 PMC3007148 · DOI
  96. Martínez-Feito A (2016) ‘ Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation’, Immunobiology, 221(1), pp. 40– 47. doi: 10.1016/j.imbio.2015.08.004. 26323380 · DOI
  97. Massaad MJ (2016) ‘ Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity’, Journal of Clinical Investigation, 126(11), pp. 4219– 4236. doi: 10.1172/JCI85647. 27760045 PMC5096910 · DOI
  98. McDermott DH (2015) ‘ Chromothriptic Cure of WHIM Syndrome’, Cell, 160(4), pp. 686– 699. doi: 10.1016/j.cell.2015.01.014. 25662009 PMC4329071 · DOI
  99. Mensa-Vilaró A (2019) ‘ Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases’, Journal of Allergy and Clinical Immunology, 143(1), pp. 359– 368. doi: 10.1016/j.jaci.2018.09.009. 30273710 · DOI
  100. Migita K (2013) ‘ The Contribution of SAA1 Polymorphisms to Familial Mediterranean Fever Susceptibility in the Japanese Population’, PLoS ONE, 8(2), pp. 1– 7. doi: 10.1371/journal.pone.0055227. PMC3577815 23437051 · DOI
  101. Minegishi Y (2007) ‘ Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome’, Nature, 448(8). doi: 10.1038/nature06096. 17676033 · DOI
  102. Moens L (2017) ‘ A novel kindred with inherited STAT2 deficiency and severe viral illness’, Journal of Allergy and Clinical Immunology, 139(6), pp. 1995– 1997.e9. doi: 10.1016/j.jaci.2016.10.033. 28087227 · DOI
  103. Molleran Lee S (2004) ‘ Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis’, Journal of Medical Genetics, 41(2), pp. 137– 144. doi: 10.1136/jmg.2003.011528. 14757862 PMC1735659 · DOI
  104. Mørk N (2015) ‘ Mutations in the TLR3 signaling pathway and beyond in adult patients with herpes simplex encephalitis’, Genes and Immunity, 16(8), pp. 552– 566. doi: 10.1038/gene.2015.46. 26513235 · DOI
  105. Nag A (2013) ‘ Chromatin signature of widespread monoallelic expression’, eLife, 2013(2), pp. 1– 19. doi: 10.7554/eLife.01256. PMC3873816 24381246 · DOI
  106. Neven B (2011) ‘ Asurvey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation’, Blood, 118(18), pp. 4798– 4807. doi: 10.1182/blood-2011-04-347641. 21885602 · DOI
  107. Newport MJ (1996) ‘ A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial Infection’, New England Journal of Medicine, 335(26), pp. 1941– 1949. doi: 10.1056/NEJM199612263352602. 8960473 · DOI
  108. Niemela JE (2011) ‘ Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis’, Blood, 117(10), pp. 2883– 2886. doi: 10.1182/blood-2010-07-295501. 21079152 PMC3062298 · DOI
  109. O’Marcaigh AS (1997) ‘ Maternal mosaicism for a novel interleukin-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred.’, Journal of clinical immunology, 17(1), pp. 29– 33. doi: 10.1023/a:1027332327827. 9049783 · DOI
  110. Oftedal BE (2015) ‘ Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases’, Immunity, 42(6), pp. 1185– 1196. doi: 10.1016/j.immuni.2015.04.021. 26084028 · DOI
  111. Orange JS (2011) ‘ Genome-wide association identifies diverse causes of common variable immunodeficiency’, Journal of Allergy and Clinical Immunology, 127(6), pp. 1360– 1367.e6. doi: 10.1016/j.jaci.2011.02.039. 21497890 PMC3646656 · DOI
  112. Picard C (2010) ‘ Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency’, Medicine, 89(6), pp. 403– 425. doi: 10.1097/MD.0b013e3181fd8ec3. 21057262 PMC3103888 · DOI
  113. Del Pino-Molina L (2019) ‘ Impaired CpG demethylation in common variable immunodeficiency associates with B cell phenotype and proliferation rate’, Frontiers in Immunology, 10(4), pp. 1– 11. doi: 10.3389/fimmu.2019.00878. 31105700 PMC6492528 · DOI
  114. Posey JE (2016) ‘ Molecular diagnostic experience of whole-exome sequencing in adult patients’, Genetics in Medicine, 18(7), pp. 678– 685. doi: 10.1038/gim.2015.142. 26633545 PMC4892996 · DOI
  115. Prando C (2013) ‘ Inherited IL-12p40 deficiency: Genetic, immunologic, and clinical features of 49 patients from 30 kindreds’, Medicine, 92(2), pp. 109– 122. doi: 10.1097/MD.0b013e31828a01f9. 23429356 PMC3822760 · DOI
  116. Puck JM (1995) ‘ Female germ line mosaicism as the origin of a unique IL-2 receptor G- chain mutation causing X-linked severe combined immunodeficiency’, Journal of Clinical Investigation, 95(2), pp. 895– 899. doi: 10.1172/jci117740. 7860773 PMC295580 · DOI
  117. Rae W (2017) ‘ Clinical efficacy of a next-generation sequencing gene panel for primary immunodeficiency diagnostics’, Clinical Genetics, 93(3), pp. 647– 655. doi: 10.1111/cge.13163. 29077208 · DOI
  118. Reinius B and Sandberg R (2015) ‘ Random monoallelic expression of autosomal genes: Stochastic transcription and allele-level regulation’, Nature Reviews Genetics. Nature Publishing Group, 16(11), pp. 653– 664. doi: 10.1038/nrg3888. 26442639 · DOI
  119. Revel-Vilk S (2015) ‘ Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation’, Clinical Immunology. Elsevier Inc., 159(1), pp. 84– 92. doi: 10.1016/j.clim.2015.04.007. 25931386 · DOI
  120. Rieux-Laucat F (1995) ‘ Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity’, Science, 268(5215), pp. 1347– 1349. doi: 10.1126/science.7539157. 7539157 · DOI
  121. Rigaud S (2011) ‘ Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG’, Blood, 118(2), pp. 252– 261. doi: 10.1182/blood-2011-01-328849. 21543760 · DOI
  122. Rodríguez-Cortez VC (2015) ‘ Monozygotic twins discordant for common variable immunodeficiency reveal impaired DNA demethylation during naïve-to-memory B-cell transition’, Nature Communications, 6. doi: 10.1038/ncomms8335. PMC4557293 26081581 · DOI
  123. Rosain J (2019) ‘ Mendelian susceptibility to mycobacterial disease: 2014–2018 update’, Immunology and Cell Biology, 97(4), pp. 360– 367. doi: 10.1111/imcb.12210. 30264912 PMC6438774 · DOI
  124. Rowczenio DM (2017) ‘ Late-onset cryopyrin-associated periodic syndromes caused by somatic NLRP3 mosaicism-UK single center experience’, Frontiers in Immunology, 8(10). doi: 10.3389/fimmu.2017.01410. PMC5671490 29163488 · DOI
  125. Sampaio EP (2012) ‘ A novel STAT1 mutation associated with disseminated mycobacterial disease’, Journal of Clinical Immunology, 32(4), pp. 681– 689. doi: 10.1007/s10875-012-9659-2. 22437822 PMC4112946 · DOI
  126. Sancho-Shimizu V (2011) ‘ Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency’, Journal of Clinical Investigation, 121(12), pp. 4889– 4902. doi: 10.1172/JCI59259. 22105173 PMC3226004 · DOI
  127. Sarrafzadeh SA (2019) ‘A New Patient with Inherited TYK2 Deficiency’, pp. 10– 13. PMC7218688 31713088
  128. Savova V (2017) ‘ Risk alleles of genes with monoallelic expression are enriched in gain-of-function variants and depleted in loss-of-function variants for neurodevelopmental disorders’, Molecular Psychiatry, 22(12), pp. 1785– 1794. doi: 10.1038/mp.2017.13. 28265118 PMC5589474 · DOI
  129. Schubert D (2014) ‘ Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations’, Nature Medicine, 20(12), pp. 1410– 1416. doi: 10.1038/nm.3746. PMC4668597 25329329 · DOI
  130. Schwab C (2018) ‘ Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects’, Journal of Allergy and Clinical Immunology, 142(6), pp. 1932– 1946. doi: 10.1016/j.jaci.2018.02.055. 29729943 PMC6215742 · DOI
  131. Shiota M (2015) ‘ Somatic Mosaicism for a NRAS Mutation Associates with Disparate Clinical Features in RAS-associated Leukoproliferative Disease: a Report of Two Cases’, Journal of Clinical Immunology, 35(5), pp. 454– 458. doi: 10.1007/s10875-015-0163-3. 25896945 · DOI
  132. Speckmann C (2008) ‘ Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency’, Blood, 112(10), pp. 4090– 4097. doi: 10.1182/blood-2008-04-153361. 18728247 · DOI
  133. Stephan V (1996) ‘ Atypical X-Linked Severe Combined Immunodeficiency Due to Possible Spontaneous Reversion of the Genetic Defect in T Cells’, New England Journal of Medicine, 335(21), pp. 1563– 1567. doi: 10.1056/NEJM199611213352104. 8900089 · DOI
  134. Stray-Pedersen A (2017) ‘ Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders’, Journal of Allergy and Clinical Immunology, 139(1), pp. 232– 245. doi: 10.1016/j.jaci.2016.05.042. 27577878 PMC5222743 · DOI
  135. Sung L (2001) ‘ The Role of Infections in Primary Hemophagocytic Lymphohistiocytosis: A Case Series and Review of the Literature’, Clinical Infectious Diseases, 33(10), pp. 1644– 1648. doi: 10.1086/323675. 11595993 · DOI
  136. Taft J and Bogunovic D (2018) ‘ The Goldilocks Zone of Type I IFNs: Lessons from Human Genetics’, The Journal of Immunology, 201(12), pp. 3479– 3485. doi: 10.4049/jimmunol.1800764. 30530500 · DOI
  137. Takagi Masatoshi (2011) ‘ Autoimmune lymphoproliferative syndrome–like disease with somatic KRAS mutation’, Blood, 117(10), pp. 2887– 2890. doi: 10.1182/blood-2010-08-301515. 21063026 · DOI
  138. Tangye SG (2020) ‘ Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee’, Journal of Clinical Immunology. Journal of Clinical Immunology. doi: 10.1007/s10875-019-00737-x. PMC7082301 31953710 · DOI
  139. Telenti A (2019) ‘ Regulatory genome variants in human susceptibility to infection’, Human Genetics. Springer Berlin Heidelberg, (0123456789). doi: 10.1007/s00439-019-02091-9. PMC7272256 31807864 · DOI
  140. Thaventhiran JED (2018) ‘ Whole Genome Sequencing of Primary Immunodeficiency reveals a role for common and rare variants in coding and non-coding sequences’, bioRxiv, p. 499988. doi: 10.1101/499988. · DOI
  141. Timberlake AT (2016) ‘ Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and common BMP2 alleles’, eLife, 5(September2016), pp. 1– 19. doi: 10.7554/eLife.20125. PMC5045293 27606499 · DOI
  142. Tone Y (2007) ‘ Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1’, Blood, 109(3), pp. 1182– 1184. doi: 10.1182/blood-2007-08-039057. 17244687 · DOI
  143. Tsumura M (2012) ‘ Dominant-negative STAT1 SH2 domain mutations in unrelated patients with mendelian susceptibility to mycobacterial disease’, Human Mutation, 33(9), pp. 1377– 1387. doi: 10.1002/humu.22113. 22573496 PMC3668973 · DOI
  144. Uberti J (1983) ‘ A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.’, Journal of Immunology, 130(6), pp. 2866– 2870. 6854019
  145. Vairo D (2011) ‘ Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation’, Blood, 118(7), pp. 1806– 1817. doi: 10.1182/blood-2011-01-330571. 21772053 · DOI
  146. de Valles-Ibáñez G (2018) ‘ Evaluating the genetics of common variable immunodeficiency: Monogenetic model and beyond’, Frontiers in Immunology, 9(5), pp. 1– 15. doi: 10.3389/fimmu.2018.00636. 29867916 PMC5960686 · DOI
  147. Vihinen M (1997) ‘ BTKbase, mutation database for X-linked agammaglobulinemia (XLA)’, Nucleic Acids Research, 25(1), pp. 166– 171. doi: 10.1093/nar/25.1.166. 9016530 PMC146405 · DOI
  148. Walker S (2016) ‘ Identification of a gain-of-function STAT3 mutation (p.Y640F) in lymphocytic variant hypereosinophilic syndrome’, Blood, 127(7), pp. 360– 363. 26702067 PMC4760095
  149. Whitley RJ and Kimberlin DW (2005) ‘ Herpes simplex: Encephalitis children and adolescents’, Seminars in Pediatric Infectious Diseases, 16(1), pp. 17– 23. doi: 10.1053/j.spid.2004.09.007. 15685145 · DOI
  150. Wolach B (2005) ‘ Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB’, Blood, 105(1), pp. 61– 66. doi: 10.1182/blood-2004-02-0675. 15308575 · DOI
  151. Yang Y (2014) ‘ Molecular findings among patients referred for clinical whole-exome sequencing’, JAMA - Journal of the American Medical Association, 312(18), pp. 1870– 1879. doi: 10.1001/jama.2014.14601. 25326635 PMC4326249 · DOI · Paper page
  152. Yel L (2010) ‘ Selective IgA Deficiency’, Journal of Clinical Immunology, 30(1), pp. 10– 16. doi: 10.1007/s10875-009-9357-x. 20101521 PMC2821513 · DOI
  153. Zhang SY (2007) ‘ TLR3 deficiency in patients with herpes simplex encephalitis’, Science, 317(5844), pp. 1522– 1527. doi: 10.1126/science.1139522. 17872438 · DOI

Cited by

Sorted by citations

Authors
Gruber, C., & Bogunovic, D.
Affiliations
Icahn School of Medicine at Mount Sinai (US)
Corresponding author
Bogunovic, Dusan
Venue
Human Genetics
Published
2020-02-17
Volume
139
Issue
6-7
Pages
745-757
ISSN
  • 0018-7348 (ISSN-L)
  • 0340-6717
  • 1432-1203
OpenAlex
W3008036448
Cited by
97
References
4
Citations by year
2026: 13 · 2025: 16 · 2024: 12 · 2023: 13 · 2022: 14 · 2021: 24 · 2020: 5
FWCI
1.39
Type
journal article
Language
en
Open access
Locations
  • Human Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Allergy and Infectious Diseases (R01AI127372, R21 AI134366, R21AI129827)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Blood disorders and treatments
Keywords
incomplete penetrance, primary immunodeficiency, genotype-phenotype discordance, epigenetic modifications, mosaicism, Mendelian inheritance, genetic heterogeneity
MeSH terms
Primary Immunodeficiency Diseases, Humans, Mosaicism, Genetic Variation, Penetrance, Genetic Predisposition to Disease, Epigenesis, Genetic, Gene-Environment Interaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review